ACTRIMS

What ACTRIMS does

ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) is a private nonprofit 501(c)(3) professional membership organization founded in 1995 and headquartered in Middleton, Wisconsin. It serves as a community of MS and neuroimmunology clinicians and researchers from the United States and Canada, with Lynda Patterson serving as Chief Executive Officer and Mark Freedman serving as President since October 2023. The organization is dedicated to knowledge dissemination, education, and collaboration across disciplines focused on MS and other demyelinating diseases, with a stated audience of nearly 1 million Americans living with MS (including over 70,000 veterans) anchoring its mission relevance.

ACTRIMS' core offerings center on the annual ACTRIMS Forum (a CE-accredited medical meeting featuring 400+ poster presentations and rotating between West Palm Beach and San Diego), didactic and patient-centered webinar series, the ACTRIMS Forum Insider Podcast, the LearnMS Online Library, and a peer-reviewed journal partnership with SAGE Publishing via the Multiple Sclerosis Journal. The organization sponsors the Neuroimmunology Fellowship Match in partnership with SF Match, runs the Early Career Clinician & Scientist Summit, and operates named lectures honoring its founders (Kenneth P. Johnson Memorial Lecture, Paty Lecture instituted in 2005). Its MS Differential Diagnosis Consortium, established with MSIF, CMSC, and ECTRIMS, published updated comprehensive guidance in The Lancet Neurology in July 2023.

The business model combines membership dues, event registration fees, and industry sponsorship. Sponsorship has been formalized into a tiered structure for Forum 2026 with four Satellite Symposium slots priced at $50,000 each and Business Suite commitments at a $10,000 minimum, alongside additional Business Pod inventory. Industry supporters include Alexion, Biogen, Genentech, Novartis, Sanofi, EMD Serono, UCB, TG Therapeutics, Immunic, Octave Bio, Neurophet, Zenas BioPharma, and Aptar Digital Health. Strategic partnerships extend to the MS Society of Canada, National Multiple Sclerosis Society, IMSVISUAL, iWiMs, NAIMS, the European Charcot Foundation, and PRIME Education. The organization maintains a lean staff of 1-10 employees and supports awards programs including the Rachel Horne Prize ($40,000 for women's MS research) and the hosting of the Barancik Prize at the ACTRIMS Forum.

Name

ACTRIMS

Legal name

Americas Committee for Treatment and Research in Multiple Sclerosis

Website

https://actrims.org

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1–10 employees

Short description

ACTRIMS is a U.S.-based nonprofit professional medical society, founded in 1995, that serves clinicians and researchers across North America through the annual ACTRIMS Forum, educational webinars, a fellowship match program, peer-reviewed publishing, and the MS Differential Diagnosis Consortium.

Ownership category

akta.pro rank

Product category

Medical Professional Association

NAICS

Professional Organizations (813920), Business Associations (813910)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAOAJAO

Clinical Research Support (CRC/CTA)

Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

SECONDARYHLAGALAK

Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

Keywords

• Multiple sclerosis research
• Medical professional society
• Continuing medical education
• Clinical fellowship programs
• Neuroimmunology education

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership: ACTRIMS generates revenue through membership fees, providing exclusive access to the Online Library, educational events, and event registration benefits.
2. Event Registration: Revenue generated from Forum registration fees for the annual ACTRIMS Forum and Early Career Clinician & Scientist Summit.
3. Industry Sponsorships and Satellite Symposia: Pharmaceutical and biotech companies sponsor the annual Forum. Four Satellite Symposia slots are available at $50,000 each. Business Suites and Business Pods are also available for sponsorship.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

ACTRIMS is a non-profit professional medical association that delivers accredited educational programming, scientific forums, webinars, podcasts, peer-reviewed publications, and fellowship matching services to advance the treatment and research of multiple sclerosis and other demyelinating diseases among clinicians and researchers in the United States and Canada. It operates the annual ACTRIMS Forum, didactic and patient-centered webinar series, the MS Journal supplemental issues, the LearnMS Online Library, the Neuroimmunology Fellowship Match, and the MS Differential Diagnosis Update consortium.

Product overview

ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) is a professional medical society founded in 1995 that serves as a community of leaders dedicated to MS treatment and research. Rather than a unified software product, ACTRIMS operates as a portfolio of educational programs, events, and clinical resources. The core offerings include the annual ACTRIMS Forum (an accredited medical conference), didactic and patient-centered webinar series, the MS Journal (peer-reviewed publication), the Neuroimmunology Fellowship Match program, and the MS Differential Diagnosis Update consortium. Supporting resources include the LearnMS Online Library, the Forum Insider Podcast, and named lectures (Kenneth P. Johnson Memorial Lecture and Paty Lecture). The organization also hosts the Early Career Clinician & Scientist Summit to foster careers of young investigators and clinicians in the field.

Differentiator

Problem solved

Functional benefit

Products and services

• ACTRIMS Forum
• Didactic Webinars
• Patient-Centered Webinars
• ACTRIMS Forum Insider Podcast
• Neuroimmunology Fellowship Match
• MS DDX Update (MS Differential Diagnosis Update)
• MS Journal (Multiple Sclerosis Journal Supplemental Issues)
• LearnMS Online Library
• ACTRIMS Early Career Clinician & Scientist Summit

Quantifiable outcome

• Over 400 poster presentations at each annual Forum
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

13 partnerships are on record, tiered core and minor.

• SF MatchcoreStrategic or Co-development PartnerSF Match facilitates the Neuroimmunology and MS Fellowship Match, sponsored by ACTRIMS. The match includes 1 to 3-year fellowship training programs focusing on clinical or combined clinical-research training in MS and other autoimmune neurologic disorders.
• Multiple Sclerosis Journal (SAGE Publishing)coreStrategic or Co-development PartnerACTRIMS Forum supplemental issues are published in the peer-reviewed Multiple Sclerosis Journal, an international journal focusing on all aspects of MS, neuromyelitis optica, and related autoimmune diseases of the CNS.
• MS Society of Canada (MSSC)coreStrategic or Co-development PartnerStanding partner organization collaborating on knowledge dissemination and education in MS research and treatment.
• National Multiple Sclerosis Society (NMSS)coreStrategic or Co-development PartnerStanding partner organization collaborating on MS research, fellowship programs, and advocacy initiatives including Barancik Prize sponsorship.
• IMSVISUAL (International Multiple Sclerosis Visual System Consortium)coreTechnology or IntegrationACTRIMS collaborates with IMSVISUAL on visual system research in MS. IMSVISUAL authored landmark paper published in The Lancet Neurology on OCT and VEPs in 2024 McDonald diagnostic criteria.
• iWiMs (International Women in Multiple Sclerosis)coreStrategic or Co-development PartneriWiMs provides parental travel grants for investigators with young children to cover childcare costs during ACTRIMS Forum. Partnership supports diversity in MS research.
• NAIMS (North American Imaging in MS Cooperative)coreTechnology or IntegrationNAIMS collaborates on imaging research and standards in MS. Listed as a valued partner in Forum 2026 collaboration.
• European Charcot FoundationcoreStrategic or Co-development PartnerECF Young Investigator Award recipient is selected by a joint jury from ACTRIMS and ECF. Award recipient joins ECF Fellowship Community and receives invitation to ECF Annual Meeting.
• MS International FederationcoreStrategic or Co-development PartnerRepresentatives from MSIF participate in the MS Differential Diagnosis Consortium (MSDDC), initiated by ACTRIMS, along with Consortium of MS Centers and ECTRIMS.
• Consortium of MS Centers (CMSC)coreStrategic or Co-development PartnerRepresentatives from CMSC participate in the MS Differential Diagnosis Consortium (MSDDC). CMSC is also a Forum 2026 supporter.
• European Committee for Treatment and Research in MS (ECTRIMS)coreStrategic or Co-development PartnerECTRIMS representatives participate in the MSDDC. ACTRIMS and ECTRIMS have collaborated on updates to McDonald Criteria and other initiatives.
• PRIME EducationminorGTM or Marketing PartnerACTRIMS partnered with PRIME to produce podcasts and quiz series on MS treatment optimization, including 'Achieving Health Equity in Multiple Sclerosis' and 'Evolving Treatment Paradigms in Multiple Sclerosis'.
• Forum 2026 Industry SupporterscoreOthersPharmaceutical and biotech companies supporting ACTRIMS Forum 2026 include Alexion, Biogen, Genentech, Novartis, Sanofi, EMD Serono, UCB, TG Therapeutics, Immunic, Octave Bio, Neurophet, Zenas BioPharma, Aptar Digital Health, and others. These supporters fund the forum through satellite symposia, business suites, and sponsorship.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• MS International Federation (MSIF): Broader incumbent: MSIF is the global MS umbrella body whose representatives participate in ACTRIMS-led MSDDC; it operates at a global level across MS societies, with overlapping reach in research dissemination and influencing WHO Essential Medicines inclusion.
• American Academy of Neurology (AAN): Broader incumbent: AAN is the dominant U.S. general neurology society; while not MS-specific, its Annual Meeting and Neurology journal are competitive vehicles for MS content and CME, and many ACTRIMS members overlap with AAN's neurology membership base.
• National Multiple Sclerosis Society (NMSS): Broader incumbent: NMSS is ACTRIMS' standing research-and-advocacy partner (it sponsors the Barancik Prize awarded at ACTRIMS Forum) and is the dominant U.S. patient-advocacy funder for MS; significant overlap in convening authority, federal research funding advocacy, and KOL relationships.
• MS Society of Canada (MSSC): Broader incumbent: MSSC is ACTRIMS' named standing partner organization for research and dissemination in Canada; comparable in mission (MS research and advocacy) but with a national, patient-advocacy focus rather than ACTRIMS' clinician-scientist focus.

Emerging players

• iWiMs (International Women in Multiple Sclerosis): Emerging player: iWiMs is a partnered global network supporting women investigators in MS; ACTRIMS already operationalizes iWiMs' parental travel grant program at Forum. iWiMs is an adjacent MS research community that increasingly competes for sponsor mindshare in the women's-MS-research space.
• NAIMS (North American Imaging in MS Cooperative): Emerging player: NAIMS is a named ACTRIMS Forum 2026 partner focused on MS imaging standards and research; it overlaps with ACTRIMS on imaging-focused scientific content and convening within the MS research community.
• International Society for Neuroimmunology (ISNI): Emerging player: ISNI is the global scientific society focused on neuroimmunology broadly (encompassing MS, NMOSD, MOGAD, autoimmune encephalitis); it competes for the same neuroimmunology research presentations and convening authority, intersecting ACTRIMS' research mandate at the subspecialty level.

Direct peers

• Consortium of Multiple Sclerosis Centers (CMSC): Direct peer: CMSC is a North American MS-focused professional organization that also convenes an annual meeting, participates in the MSDDC alongside ACTRIMS, and runs its own CME, research, and clinical practice programs targeting the same MS clinician audience.
• European Charcot Foundation (ECF): Direct peer: ECF is a Europe-based MS research foundation that runs an annual scientific meeting and jointly selects the ECF Young Investigator Award with ACTRIMS; both operate fellowship and young-investigator programs for emerging MS researchers.
• European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS): Direct peer: ECTRIMS is ACTRIMS' European counterpart and the other foundational medical society dedicated to MS research and treatment; they co-author McDonald criteria updates and co-lead the MSDDC consortium, and both organizations run annual scientific forums that compete for the same global KOLs and sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ACTRIMS
• Facebookfacebook.com/ACTRIMS
• LinkedInlinkedin.com/company/americas-committee-for-treatment-&-research-in-multiple-sclerosis-actrims-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACTRIMS